Literature DB >> 10216789

Is donepezil effective for treating Alzheimer's disease?

L S Steele1, R H Glazier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10216789      PMCID: PMC2328349     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  6 in total

1.  Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

Authors:  S L Rogers; R S Doody; R C Mohs; L T Friedhoff
Journal:  Arch Intern Med       Date:  1998-05-11

Review 2.  Alzheimer's disease: current knowledge, management and research.

Authors:  S Gauthier; M Panisset; J Nalbantoglu; J Poirier
Journal:  CMAJ       Date:  1997-10-15       Impact factor: 8.262

3.  Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study.

Authors:  S L Rogers; L T Friedhoff
Journal:  Eur Neuropsychopharmacol       Date:  1998-02       Impact factor: 4.600

4.  A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group.

Authors:  S L Rogers; M R Farlow; R S Doody; R Mohs; L T Friedhoff
Journal:  Neurology       Date:  1998-01       Impact factor: 9.910

5.  The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group.

Authors:  S L Rogers; L T Friedhoff
Journal:  Dementia       Date:  1996 Nov-Dec

6.  Relation between severity of Alzheimer's disease and costs of caring.

Authors:  M J Hux; B J O'Brien; M Iskedjian; R Goeree; M Gagnon; S Gauthier
Journal:  CMAJ       Date:  1998-09-08       Impact factor: 8.262

  6 in total
  6 in total

1.  Effectiveness of donepezil in treating Alzheimer's disease.

Authors:  A Garcia
Journal:  Can Fam Physician       Date:  1999-08       Impact factor: 3.275

2.  A Therapeutic Insight of Niacin and Coenzyme Q10 Against Diabetic Encephalopathy in Rats.

Authors:  Tarek K Motawi; Hebatallah A Darwish; Manal A Hamed; Nagy S El-Rigal; Asmaa F Aboul Naser
Journal:  Mol Neurobiol       Date:  2016-02-11       Impact factor: 5.590

Review 3.  Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.

Authors:  Krista L Lanctôt; Nathan Herrmann; Kenneth K Yau; Lyla R Khan; Barbara A Liu; Maysoon M LouLou; Thomas R Einarson
Journal:  CMAJ       Date:  2003-09-16       Impact factor: 8.262

Review 4.  Salivary Secretory Disorders, Inducing Drugs, and Clinical Management.

Authors:  Jaume Miranda-Rius; Lluís Brunet-Llobet; Eduard Lahor-Soler; Magí Farré
Journal:  Int J Med Sci       Date:  2015-09-22       Impact factor: 3.738

5.  Comprehensive Exploration of Target-specific Ligands Using a Graph Convolution Neural Network.

Authors:  Yu Miyazaki; Naoaki Ono; Ming Huang; Md Altaf-Ul-Amin; Shigehiko Kanaya
Journal:  Mol Inform       Date:  2019-12-09       Impact factor: 3.353

6.  Precision Medicine of Sodium Benzoate for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD).

Authors:  Chieh-Hsin Lin; Hui-Ting Yang; Ping-Kun Chen; Shi-Heng Wang; Hsien-Yuan Lane
Journal:  Neuropsychiatr Dis Treat       Date:  2020-02-20       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.